CDC Identifies Next Priority Groups for COVID Vaccine


Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.

An influential federal advisory panel on Sunday voted to recommend that the elderly and certain essential workers be the next groups of Americans to get access to limited doses of COVID-19 vaccine.

The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) voted 13-1 on the recommendation. 

The first group of people to have access to COVID-19 vaccines, the Phase 1a group, remains healthcare workers and residents of long-term care facilities, as ACIP recommended earlier this month.

The next set of recipients, the Phase 1b group, will include people aged 75 years and older and certain front-line essential workers. The third group, Phase 1c, will include other essential workers and people aged 16-64 years with high-risk medical conditions.

The three ACIP members who had conflicts that prevented their voting were Robert L. Atmar, MD, who said at the Saturday meeting he had participated in COVID-19 trials, including research on the Moderna vaccine; Sharon E. Frey, MD, who said at the Saturday meeting that she had been involved with research on COVID-19 vaccines, including Moderna’s; and Paul Hunter, MD, who said he has received a grant from Pfizer for pneumococcal vaccines. The other panel members have reported no relevant financial relationships.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube.

Products You May Like

Articles You May Like

Bispecific antibody exhibits high breadth and potency against SARS-CoV-2 Omicron sub-lineages
5 essential questions to reconnect you with your career path and reignite your job spark
Study: Higher Insulin Doses May Increase Cancer Risks in Type 1 Diabetes
Want to improve your relationship? The answer may be simpler than you think
CHOP helps launch new computational platform to harmonize pediatric cancer data

Leave a Reply

Your email address will not be published.